MedNation (EIF.F) Stock Price

MedNation Price

Delisted
3.70EUR
Last traded price
Today +/-
Today %

MedNation (EIF.F) Stock | ISIN DE0005653604 | WKN 565360. The current MedNation stock price is 3.7 EUR (2026). Market capitalization is 3.52 M EUR. MedNation operates in the Health sector.

Revenue has compounded at 1.5% per year over the past 19 years to 48.76 M EUR. Earnings per share have grown at 3.5% per year over the last 19 years. MedNation's net margin stands at 0.2%, up from -4% several years earlier. MedNation currently offers a dividend yield of about 11.08%. The dividend has grown at 15.9% per year over the past 12 years.

MedNation stock price

Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of MedNation over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how MedNation stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing MedNation's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

MedNation Stock Price History
DateMedNation Price
Access this data via the Eulerpool API

MedNation Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2005
36.8 M EUR
1.88 M EUR
180,000 EUR
Jan 1, 2006
36.91 M EUR
2.77 M EUR
880,000 EUR
Jan 1, 2007
38.26 M EUR
2.95 M EUR
1.08 M EUR
Jan 1, 2008
38.87 M EUR
3.39 M EUR
1.6 M EUR
Jan 1, 2009
38.82 M EUR
2.51 M EUR
1.15 M EUR
Jan 1, 2010
39.33 M EUR
2.7 M EUR
1.41 M EUR
Jan 1, 2011
38.41 M EUR
2.39 M EUR
1.48 M EUR
Jan 1, 2012
38.98 M EUR
1.72 M EUR
660,000 EUR
Jan 1, 2013
39.33 M EUR
1.33 M EUR
-160,000 EUR
Jan 1, 2014
42.81 M EUR
1.93 M EUR
34,400 EUR
Jan 1, 2015
45.98 M EUR
1.26 M EUR
-968,400 EUR
Jan 1, 2016
47.78 M EUR
1.31 M EUR
4.51 M EUR
Jan 1, 2017
46.94 M EUR
602,800 EUR
-114,400 EUR
Jan 1, 2018
49.32 M EUR
226,200 EUR
-1.11 M EUR
Jan 1, 2019
48.45 M EUR
2.34 M EUR
-773,300 EUR

MedNation Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 17, 2026, 9:49 AM
 
REVENUE (M EUR)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M EUR)
NET INCOME (M EUR)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
20172018201920202021202220232024
4649483535374548
-2.136.52-2.04-27.085.7121.626.67
97.8395.9295.8397.1497.1494.5984.4493.75
4547463434353845
0-10-1-4-100
300-75
3.023.023.023.023.023.023.010.95
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales MedNation generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue MedNation retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare MedNation's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares MedNation has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against MedNation's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

MedNation stock margins

The MedNation margin analysis displays the gross margin, EBIT margin, as well as the profit margin of MedNation. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for MedNation.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2005
93.45 %
5.11 %
0.49 %
Jan 1, 2006
93.52 %
7.5 %
2.38 %
Jan 1, 2007
93.7 %
7.71 %
2.82 %
Jan 1, 2008
93.57 %
8.72 %
4.12 %
Jan 1, 2009
85.7 %
6.47 %
2.96 %
Jan 1, 2010
93.8 %
6.86 %
3.59 %
Jan 1, 2011
93.99 %
6.22 %
3.85 %
Jan 1, 2012
93.92 %
4.41 %
1.69 %
Jan 1, 2013
94 %
3.38 %
-0.41 %
Jan 1, 2014
84.19 %
4.52 %
0.08 %
Jan 1, 2015
81.83 %
2.75 %
-2.11 %
Jan 1, 2016
95.82 %
2.74 %
9.44 %
Jan 1, 2017
95.95 %
1.28 %
-0.24 %
Jan 1, 2018
96.01 %
0.46 %
-2.25 %
Jan 1, 2019
96.34 %
4.83 %
-1.6 %

MedNation Stock Revenue, EBIT, Earnings per Share

The MedNation earnings per share therefore indicates how much revenue MedNation has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2005
11.79 EUR
0.6 EUR
0.06 EUR
Jan 1, 2006
11.83 EUR
0.89 EUR
0.28 EUR
Jan 1, 2007
12.26 EUR
0.95 EUR
0.35 EUR
Jan 1, 2008
12.46 EUR
1.09 EUR
0.51 EUR
Jan 1, 2009
12.44 EUR
0.8 EUR
0.37 EUR
Jan 1, 2010
12.61 EUR
0.87 EUR
0.45 EUR
Jan 1, 2011
12.39 EUR
0.77 EUR
0.48 EUR
Jan 1, 2012
12.66 EUR
0.56 EUR
0.21 EUR
Jan 1, 2013
12.98 EUR
0.44 EUR
-0.05 EUR
Jan 1, 2014
14.21 EUR
0.64 EUR
0.01 EUR
Jan 1, 2015
15.27 EUR
0.42 EUR
-0.32 EUR
Jan 1, 2016
15.83 EUR
0.43 EUR
1.49 EUR
Jan 1, 2017
15.56 EUR
0.2 EUR
-0.04 EUR
Jan 1, 2018
16.34 EUR
0.07 EUR
-0.37 EUR
Jan 1, 2019
16.06 EUR
0.78 EUR
-0.26 EUR

MedNation business model & stock analysis

The Eifelhoehen Klinik AG is a first-class healthcare organization based in Germany. It is known for its high-quality medical services and top-notch facilities provided to its patients. The history of the Eifelhoehen Klinik AG dates back to 1994 when it was founded as a non-profit GmbH by a group of specialized doctors. The founders aimed to establish a clinic specializing in the treatment of cardiovascular diseases while providing the best possible therapy and care quality. Over the years, the Eifelhoehen Klinik AG has continuously grown and evolved into a leading provider of medical services in Germany. The business model of the Eifelhoehen Klinik AG is to offer comprehensive medical care to its patients based on the latest scientific knowledge and state-of-the-art technology. The clinic has a wide range of experienced specialized doctors, nursing staff, and other medical personnel who focus on the well-being and recovery of the patients. One of the main specialties of the Eifelhoehen Klinik AG is cardiology, where all types of cardiovascular diseases are treated, from diagnostics to therapy, rehabilitation, and follow-up care. The team of cardiologists and specialized doctors work closely together to create individual treatment plans tailored to the needs of each patient. Another important specialty of the Eifelhoehen Klinik AG is orthopedics and trauma surgery. Through its intensive collaboration with experienced surgeons and rehabilitation specialists, the clinic offers personalized care to its patients. Here, all types of joint, bone, and spine diseases are treated, including hip osteoarthritis, herniated discs, scoliosis, and osteoporosis. The Eifelhoehen Klinik AG also offers a range of other professional services to its patients, such as diagnostic radiology, gastroenterology, urology, gynecology, and vascular surgery. To provide comprehensive rehabilitation after surgeries, the clinic also offers psychological support and pain therapy applications. The Eifelhoehen Klinik AG also has some special offerings, especially in the field of medical wellness. Here, patients enjoy first-class accommodation as well as individual support and advice regarding stress reduction and lifestyle changes. All of this contributes to their ability to live healthier and happier lives. Overall, the Eifelhoehen Klinik AG is one of the leading medical facilities in Germany. With its top-class range of medical and wellness services, experienced specialized doctors, and state-of-the-art technology, it is able to provide its patients with first-class care.

MedNation SWOT Analysis

Strengths

Eifelhoehen Klinik AG possesses several strengths that contribute to its success. These include:

  • Highly skilled and experienced medical staff
  • State-of-the-art medical equipment and facilities
  • Strong reputation for providing quality healthcare services
  • Strategic location in a popular tourist destination

Weaknesses

Despite its strengths, Eifelhoehen Klinik AG also faces certain weaknesses which need to be addressed:

  • Limited financial resources compared to larger competitors
  • Relatively smaller scale of operations
  • Dependency on a single market segment (e.g., medical tourism)

Opportunities

Eifelhoehen Klinik AG can capitalize on the following opportunities to further enhance its growth:

  • Increasing demand for medical tourism in the region
  • Expansion of services to cater to a broader range of medical conditions
  • Collaboration with local hotels and tourist agencies
  • Growing trend of wellness and preventive healthcare

Threats

Eifelhoehen Klinik AG should be cautious about the following threats that may impact its operations:

  • Intense competition from larger, established hospitals
  • Changes in government regulations regarding medical tourism
  • Economic instability and fluctuating exchange rates
  • Challenges in attracting and retaining skilled medical professionals

MedNation Eulerpool Fair Value

MedNation historical P/E ratio, EBIT multiple, and P/S ratio

MedNation annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

MedNation shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2005
3.12 M base_Shares
Jan 1, 2006
3.12 M base_Shares
Jan 1, 2007
3.12 M base_Shares
Jan 1, 2008
3.12 M base_Shares
Jan 1, 2009
3.12 M base_Shares
Jan 1, 2010
3.12 M base_Shares
Jan 1, 2011
3.1 M base_Shares
Jan 1, 2012
3.08 M base_Shares
Jan 1, 2013
3.03 M base_Shares
Jan 1, 2014
3.01 M base_Shares
Jan 1, 2015
3.01 M base_Shares
Jan 1, 2016
3.02 M base_Shares
Jan 1, 2017
3.02 M base_Shares
Jan 1, 2018
3.02 M base_Shares
Jan 1, 2019
3.02 M base_Shares

MedNation Dividend History

14 years of dividend payments

YearAnnual DividendYoY ChangePayments
20170.41EUR 412.5%
20150.08EUR 0.0%
20140.08EUR 60.0%
20130.05EUR 66.7%
20120.15EUR 0.0%
20110.15EUR 25.0%
20100.12EUR 20.0%
20090.15EUR 114.3%
20050.07EUR 16.7%
20040.06EUR 50.0%

MedNation dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2005
116.67 %
Jan 1, 2006
268.14 %
Jan 1, 2007
268.14 %
Jan 1, 2008
268.14 %
Jan 1, 2009
40.54 %
Jan 1, 2010
26.67 %
Jan 1, 2011
31.25 %
Jan 1, 2012
71.43 %
Jan 1, 2013
-100 %
Jan 1, 2014
701.75 %
Jan 1, 2015
-24.88 %
Jan 1, 2016
268.14 %
Jan 1, 2017
-1,081.79 %
Jan 1, 2018
347.11 %
Jan 1, 2019
439 %
Price targets and forecasts for MedNation are not yet available.

MedNation shareholder structure

% Name
82.4021%
Fortmeier (Bruno)
Fortmeier (Bruno)
66.07252%
MEDIQON Group AG
MEDIQON Group AG
35.05286%
Graaler GmbH & Co. Immobilien KG
Graaler GmbH & Co. Immobilien KG
11.38875%
Scherzer & Co AG
Scherzer & Co AG

MedNation Executives and Management Board

MK

Dr. Markus-Michael Kuethmann

Chairman of the Management Board · since 2015

Compensation270,000 EUR
DL

Dipl. oec. Lothar Lotzkat

Member of the Management Board

Compensation204,000 EUR
DL

Dipl. oec. Joerg Leue

(58)

Chairman of the Supervisory Board · since 2009

Compensation62,000 EUR
DM

Ms. Doris Muecke

(60)

Independent Member of the Supervisory Board · since 2017

Compensation46,000 EUR
KD

Mr. Klaus Dirks

Vice Chairman of the Supervisory Board · since 2020

Frequently asked questions about MedNation

The business model of Eifelhoehen Klinik AG revolves around providing comprehensive healthcare services, specifically in the field of medical tourism. As a leading healthcare provider, Eifelhoehen Klinik AG focuses on offering top-notch medical treatments, state-of-the-art facilities, and personalized care to patients from around the world. Their business model incorporates a range of specialized medical services such as surgeries, diagnostics, rehabilitation, and wellness programs. By combining advanced medical expertise with a relaxing environment and holistic approach, Eifelhoehen Klinik AG aims to deliver exceptional healthcare experiences for individuals seeking high-quality treatments in a tranquil setting.

All fundamentals and in-depth analysis of MedNation

Our stock analysis for MedNation Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MedNation Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.